Patent Expiry of Blockbuster Drugs and Biomolecules—Primary Driver of the Thermal Analysis Market

"Thermal Analysis Market by Product (DSC, TGA, STA, DTA, TMA, DMA, Pressure Differential Scanning Calorimetry), Functionality (Single, Simultaneous), End User (Pharma-Biotech Co, Food Processing Co, Petrochemical Co, Academia) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 640.7 Million by 2022 from USD 511.5 Million in 2017, at a CAGR of 4.6%.

Browse 66 Market Data Tables and 34 Figures spread through 152 Pages and in-depth TOC on "Thermal Analysis Market"

http://www.marketsandmarkets.com/Market-Reports/thermal-analysis-market-1131989.html
Early buyers will receive 10% customization on this report

The differential scanning calorimetry (DSC) analyzers segment is estimated to account for the largest share of the Thermal Analysis Market in 2017 

On the basis of product, the market is categorized into differential scanning calorimetry analyzers, thermogravimetric analyzers, simultaneous thermal analyzers, differential thermal analyzers, thermomechanical analyzers, dynamic mechanical analyzers, and other thermal analyzers. The large share of the differential scanning calorimetry analyzers segment is attributed to the rising adoption of DSC analyzers in the food industry, technological advancements, the ease of use and speed offered by these products, and significant applications of these analyzers in fields such as microfluidics, drug discovery, pharmaceuticals, molecular biology, and nanoscience.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1131989

Chemical & material manufacturers are expected to hold the largest end users share of the market in 2017 

By end user, the Thermal Analysis Market is segmented into pharmaceutical & biotechnology companies, chemical & material manufacturers, food & beverage industry, petrochemical industry, research & academia, and other end users. In 2017, the chemical & material manufacturers segment is expected to hold the largest share of the Thermal Analysis Market. Growth in key end-use industries of chemicals, polymers, and materials (such as automotive, construction, electronics, healthcare, textiles, and FMCG) is the major factor driving the growth of this end-user segment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=1131989

North America is expected to dominate the Thermal Analysis Market during the forecast period 

Geographically, the Thermal Analysis Market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global Thermal Analysis Market during the forecast period (2017-2022). The growth of the North American region is attributed increasing industrial R&D expenditures across various end-user industries; availability of private-public funding for research studies, stringent regulatory norms for drug development; and strict food and product safety regulations.

The major players operating in the Thermal Analysis Market include Waters (US), NETZSCH (Germany), LINSEIS (Germany), Mettler-Toledo (US), PerkinElmer (US), SETARAM (France), and Shimadzu (Japan).

As rising adoption of minimally invasive surgical procedures across major countries demanding guidewires market

"Guidewires Market  by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022", published by MarketsandMarkets™

The market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%.

Browse 66 tables and 39 figures spread through 156 pages and in-depth TOC on "Guidewires Market"

https://www.marketsandmarkets.com/Market-Reports/guidewire-market-8118028.html

Early buyers will receive 10% customization on reports

Factors such as the rising adoption of minimally invasive surgical procedures across major countries, rising prevalence of target diseases and the increasing applications of guidewires are driving the growth of the market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=8118028

Based on material, the nitinol guidewires segment is estimated to have the largest share of the market in 2017. 

Based on material, the market is categorized into nitinol guidewires, stainless steel guidewires, and hybrid guidewires. The nitinol guidewires segment accounted for the major share of the market owing to the increasing applications of nitinol guidewires, the growing number of target medical procedures that utilize nitinol guidewires and growing patient preference for minimally invasive surgeries.

Based on product, the surgical guidewires segment is expected to witness the highest growth during the forecast period. 

On the basis of product, the guidewires market is categorized into diagnostic guidewires (further subsegmented into hydrophilic and hydrophobic diagnostic guidewires) and surgical guidewires (further subsegmented into hydrophilic and hydrophobic surgical guidewires). In 2017, the surgical guidewires segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to availability of reimbursements for vascular treatment procedures across developed countries, increasing number of surgical treatment for coronary, peripheral & neurovascular diseases, and the growing regulatory mandate implemented across developed countries related to the prevention of healthcare associated infections (HAI).

Based on end user, the hospitals, diagnostic centers, and surgical centers segment is expected to witness the highest growth during the forecast period. 

Based on end user, the market is segmented into hospitals, diagnostic centers, and surgical centers; ambulatory care centers; and research laboratories & academic institutes. The hospitals, diagnostic centers and surgical centers segment is expected to register the highest CAGR during the forecast period. This is attributed to ongoing technological advancements in the field of minimally invasive or image-guided medical procedures and growing availability of healthcare reimbursements across major countries for minimally invasive medical procedures that covers guidewires.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=8118028

North America is expected to dominate the guidewires market in 2017. 

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as strong market presence of key OEMs (that replicates into easy availability of guidewires) and the large target patient population base (those undergoing minimally invasive surgical procedures) are driving the growth of the North American guidewires market. However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to increasing number of surgical and diagnostic procedures performed in the region (coupled with the growing burden of target diseases) and modernization & expansion of healthcare infrastructure across key APAC countries.

Key Market Players: 

Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).

Airway Management Devices Market - Forecast to 2023

The global airway management devices market was valued at USD 1.52 billion in 2017 and is projected to reach USD 2.10 billion by 2023, at a CAGR of 5.6% during the forecast period. Base year considered for the report is 2017 and the forecast period considered for this report is 2018–2023.

Objectives of the Study

• To define, measure, and describe the global market by type, end user, patient age, and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
• To strategically analyze the market structure and profile key players in the global market and comprehensively analyze their core competencies
• To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; acquisitions; product approvals; and product launches in the market

Download FREE Brochure @  https://www.marketsandmarkets.com/pdfdownload.asp?id=116806061

Scope of the Report:

The research report categorizes the market into the following segments and subsegments:

Airway Management Devices Market, by Type

• Supraglottic Devices
  • Laryngeal Mask Airways
  • Oropharyngeal Airways
  • Nasopharyngeal Airways
  • Other Supraglottic Devices
• Infraglottic Devices
  • Endotracheal Tubes
  • Tracheostomy Tubes
• Laryngoscopes
• Resuscitators
• Other Airway Management Devices

Airway Management Devices Market, by End User

• Operating Rooms
• Emergency Care Department
• Intensive Care Units
• Other End Users

Airway Management Devices Market, by Patient Age

• Adult Patients
• Pediatric Patients/Neonates

Airway Management Devices Market, by Region

• North America
• Europe
• Asia Pacific
• Rest of the World

To Know More @ https://www.marketsandmarkets.com/Market-Reports/airway-management-device-market-116806061.html

Biological Safety Cabinet Market by Type & End User - 2022 | MarketsandMarkets

The biological safety cabinets market was valued at USD 137.5 Million in 2016 and is projected to reach USD 205.9 Million by 2022 at a CAGR of 7.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Objectives of the Study

To define, describe, and forecast the global biological safety cabinets market by type, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To analyze micromarkets with respect to indivi
dual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast size of market segments with respect to the four key regions - North America, Europe, Asia Pacific, and RoW
To analyze the market structure and profile key players of the global biological safety cabinets market and comprehensively analyze their core competencies
To analyze the competitive landscape of the major players operating in the biological safety cabinets market

To Know More @ https://www.marketsandmarkets.com/Market-Reports/biological-safety-cabinet-market-60228904.html

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid (CSF) management market and estimate the size of other dependent submarkets. Various secondary sources such as American Biological Safety Association (ABSA), International Federation of Biosafety Associations (IFBA), International Society of Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Society for In Vitro Biology (SIVB), Controlled Environment Testing Association (CETA), Asia Pacific Biosafety Association (APBA), Canadian Association for Biological Safety (CABS-ACSB), Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as

To know about the assumptions considered for the study, download the pdf brochure

The major market players in the biological safety cabinets market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco Corporation (US), The Baker Company (US), Kewaunee Scientific Corporation (US), NuAire (US), Germfree Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science LLC (US), Berner International (Germany), and BIOBASE (China).

Target Audience:

Government and private research institutes
Manufacturers and suppliers of biological safety cabinets
Pharmaceutical and biopharmaceutical companies
Academic and research institutes
Venture capitalists
Medical research centers
Research and consulting firms
Scope of the Report:

[Healthcare IT Market Research Reports & Consulting ]Market Research Reports & Consulting

Professional Dental Care Market worth 961.0 Million USD by 2021

"Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021", published by MarketsandMarkets, the market witnessed moderate growth during the last decade and is expected to grow at a CAGR of 4.5% between 2016 and 2021 to reach USD 961.0 Million by 2021.

Browse 172 market data Tables and 26 Figures spread through 178 Pages and in-depth TOC on "Professional Dental Care Market"

http://www.marketsandmarkets.com/Market-Reports/professional-dental-care-market-210346692.html

Early buyers will receive 10% customization on this report. 

The growth in this market is majorly attributed to factors such as increasing small/private dental clinics, rising incidences of dental caries, increasing disposable incomes in emerging countries, growing awareness about dental hygiene, and economic gain for dental practitioners.

The global Professional Dental Care Market is segmented based on product type and geography. In recent years, the dental industry is gaining more importance due to increased demand of having specialized products, treatments and procedures to treat dental diseases. In 2015, toothpastes segment accounted for the largest share of global Professional Dental Care Market. The toothbrushes segment is expected to witness the fastest growth over the next five years. The high growth of this segment can be attributed to higher utilization of the manual toothbrushes by end-users and recent technological advancements in the electric toothbrushes.

Speak To Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=210346692

Europe is the largest regional segment for Professional Dental Care Market owing to the well-established dental market. The largest share of this regional segment is driven by the increase in the aging population, rising demand for the advance oral care products, increase in governmental expenditure on oral healthcare across Europe, and rising awareness about dental hygiene.

However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising geriatric population, rising awareness about dental hygiene, and increase medical tourism in countries such as India and China. The market players, namely, Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), GlaxoSmithKline plc (U.K.), and Unilever plc (U.K.) held the major share of the Professional Dental Care Market and will continue to dominate the market between 2016 and 2021.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=210346692

Some of the other players operating in Professional Dental Care Market are Johnson and Johnson (U.S.), Dr. Fresh, LLC (U.S.), Young Innovation Inc. (U.S.), Ultradent Products, Inc. (U.S.), GC Corporation (Japan), Henkel AG & Company, KGaA (Germany), 3M Company (U.S.), Koninklijke Philips N.V. (Netherlands), and Sunstar (Japan).    

Prosthetic Heart Valve Market Industry Analysis, Size, Share, Growth, Trends and Forecast to 2022

The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%. Market growth can be attributed to the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

Years considered for this report

2016 – Base Year
2017 – Estimated Year
2022 – Projected Year

The objectives for this study are as follows:

• To define, describe, and forecast the prosthetic heart valve market on the basis of type of valve and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
• To profile the key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
• To track and analyze competitive developments such as marketing and promotional activities, approvals, product launches, acquisitions, agreements, collaborations, expansions, certifications, and reimbursement approvals in the prosthetic heart valves market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the prosthetic heart valve market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by type of valve and region) through percentage splits from secondary and primary research. For the calculation of each type of specific market segment, the most appropriate immediate parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. The bottom-up approach was employed to arrive at the overall size of the market from the sales of prosthetic heart valves in the respective four regions. Various secondary sources such as directories, industry journals, and databases have been used to identify and collect information useful for this extensive commercial study of the prosthetic heart valve market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the prosthetic heart valve market. The breakdown of primaries is shown in the figure below:

​

To know about the assumptions considered for the study, download the pdf brochure

The key players in the artificial heart valve market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).

Target Audience for this Report:

• Prosthetic Heart Valve Manufacturing Companies
• Suppliers and Distributors of Prosthetic Heart Valves
• Healthcare Service Providers
• Teaching Hospitals and Academic Medical Centers (AMCs)
• Health Insurance Players
• Research and Consulting Firms
• Medical Research Institutes
• Audiology Centers
• Healthcare Institutions/Providers (Hospitals, Medical Institutes, and Governing Bodies)
• Venture Capitalists
• Community Centers
• Regulatory Authorities

To Know More @ https://www.marketsandmarkets.com/Market-Reports/prosthetic-heart-valve-market-245407958.html

Biological Safety Cabinet Market by Type & End User - 2022 | MarketsandMarkets

The biological safety cabinets market was valued at USD 137.5 Million in 2016 and is projected to reach USD 205.9 Million by 2022 at a CAGR of 7.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Objectives of the Study

• To define, describe, and forecast the global biological safety cabinets market by type, end user, and region
• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast size of market segments with respect to the four key regions - North America, Europe, Asia Pacific, and RoW
• To analyze the market structure and profile key players of the global biological safety cabinets market and comprehensively analyze their core competencies
• To analyze the competitive landscape of the major players operating in the biological safety cabinets market

To Know More @ https://www.marketsandmarkets.com/Market-Reports/biological-safety-cabinet-market-60228904.html

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid (CSF) management market and estimate the size of other dependent submarkets. Various secondary sources such as American Biological Safety Association (ABSA), International Federation of Biosafety Associations (IFBA), International Society of Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Society for In Vitro Biology (SIVB), Controlled Environment Testing Association (CETA), Asia Pacific Biosafety Association (APBA), Canadian Association for Biological Safety (CABS-ACSB), Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as 

well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

                                             

To know about the assumptions considered for the study, download the pdf brochure

The major market players in the biological safety cabinets market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco Corporation (US), The Baker Company (US), Kewaunee Scientific Corporation (US), NuAire (US), Germfree Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science LLC (US), Berner International (Germany), and BIOBASE (China).

Target Audience:

• Government and private research institutes
• Manufacturers and suppliers of biological safety cabinets
• Pharmaceutical and biopharmaceutical companies
• Academic and research institutes
• Venture capitalists
• Medical research centers
• Research and consulting firms

Scope of the Report:

 [Healthcare IT Market Research Reports & Consulting ]Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Ophthalmology PACS Market 2018 Industry Analysis, Size, Share, Growth, Trends and Forecast to 2023

The ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 101.0 million in 2017, at a CAGR of 8.5% during the forecast period. The base year considered for the study of ophthalmology PACS Industry is 2017 and the forecast period is from 2018 to 2023.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=130879968

The Objectives of this Study are as follows:

• To define, describe, and forecast the ophthalmology PACS market by type, delivery model, end user, and region
• To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the market size of market segments in North America, Europe, Asia, Pacific countries, and the Rest of the World (RoW)
• To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies3
• To track and analyze competitive developments such as partnerships, agreements, and collaborations; mergers & acquisitions; product launches and enhancements; and expansions in the ophthalmology PACS market

Drivers

Rapid growth in the geriatric population

Over the years, there has been a significant increase in the geriatric population and, subsequently, the prevalence of age-related disorders, including a number of eye disorders. This is a key factor driving the demand for innovative technologies for the diagnosis and treatment of ophthalmic conditions. The tear layer loses stability and degrades faster in the elderly; consequently, the risk of getting severe eye disorders increases significantly with age, particularly after 60 years. One in three elderly people suffers from some form of eye diseases and is at risk of severe eye problems. These conditions include age-related macular degeneration, cataract, low vision, glaucoma, and diabetic eye disease.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/ophthalmology-pacs-market-130879968.html

Rising prevalence of eye diseases

The number of people with major eye diseases is increasing across the globe, and vision loss is becoming a major public health concern. The growth in aging population and the increasing prevalence of chronic disorders such as diabetes and hypertension have also served to boost the prevalence of eye diseases such as diabetic retinopathy and ocular hypertension (glaucoma). The number of blind individuals or those affected with low vision is expected to increase substantially.

According to the Royal National Institute of Blind People (RNIB), in 2013, around 2 million people in the UK were living with sight loss, which is expected to increase to 4.1 million by 2050. According to the WHO, an estimated 20 million cataract surgeries were performed in 2010 across the globe; this is expected to reach 32 million by 2020.

[Healthcare IT Market Research Reports & Consulting ]Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/ophthalmology-pacs-market.asp

Increasing Focus on Personalized Medicine to Boost the Nuclear Imaging Market Growth

"Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2021", that analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Factors driving the global market include introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new 

radiotracers, and increasing incidence and prevalence of cancer & cardiovascular diseases.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=98

This market is expected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8%.

However, factors such as shutdown of National Research Universal (NRU) reactor, high cost of nuclear imaging equipment, and shorter half-life of radiopharmaceuticals are hindering the growth of the market.

The global nuclear imaging equipment market is segmented on the basis of product, application, end user, and region.

Nuclear Imaging Equipment Market, by Product

• SPECT Systems
  • Hybrid SPECT
  • Standalone SPECT
• Hybrid PET Systems
• Planar Scintigraphy

Nuclear Imaging Equipment Market, by Application

• Oncology
• Cardiology
• Neurology
• Other Applications (Orthopedics, Urology, Thyroid-related Disorders, and Gastroenterology)

Nuclear Imaging Equipment Market, by End User

• Hospitals
• Imaging Centers
• Academic and Research Centers
• Other End Users (Pharmaceutical/Biotechnology Companies and CROs)

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.).These companies are dominant in the nuclear imaging market mainly due to their well-established presence in the field of medical imaging, presence in over 50 countries, high R&D investments, and strong sales and distribution force.

The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/nuclear-imaging-equipment-market-98.html

A New Trend in Molecular Diagnostics - Point of Care Molecular Diagnostics

The global POC molecular diagnostics market is projected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%.

Growth in the POC molecular diagnostics market is driven by the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. Growing R&D activities in molecular diagnostic testing and the increasing penetration of POC molecular diagnostic tests in China, India, and Brazil are also expected to provide a wide range of growth opportunities for players in the market.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=143524127

In this report, the market is segmented by product & service, technology, application, end user, and region. On the basis of product & service, the global POC molecular diagnostics market is segmented into assays and kits, instruments, and software & services. The assay and kits segment is expected to be the fastest-growing segment of the POC molecular diagnostics market in 2018. An increasing number of assays and kits in this market have been granted the CLIA-waived status, which defines that the product can be used for decentralized settings or nontraditional laboratories, including physicians’ offices, emergency rooms, and health department clinics. As a result, their applications have increased, making them the largest segment.

Based on application, the POC molecular diagnostics market is segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications. The oncology segment is expected to be the fastest growing market owing to the rising prevalence of cancer, and investments in cancer research across the globe.

By technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and others (DNA sequencing and microarrays). INAAT is expected to be the fastest growing technology during the forecast period due to the increasing popularity of INAAT for infectious diseases diagnosis.

Geographically, POC molecular diagnostics market is segmented into four major regions—North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to be the fastest growing market. The key factors influencing the growth of this market include growing initiatives by market players, rising demand for influenza A/B tests, decentralized healthcare delivery systems, and increasing patient population base in this region.

To Know More, Speak To Analyst @ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=143524127